Meanwhile, we identified that PGC-1β interacts with FOXA2, and it synergizes with FOXA2 to inhibit the biological functions of breast cancer cells through regulating the PI3K-AKT-mTOR signaling pathway. This evidence concerns the gene PPARGC1B and breast cancer.